LM Funding America (LMFA) Stock Price, News & Analysis

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LM Funding America in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" LMFA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LMFA, but not buy additional shares or sell existing shares.
View LMFA analyst ratings or view top-rated stocks.

LM Funding America's stock was trading at $3.6990 at the beginning of 2024. Since then, LMFA shares have decreased by 30.0% and is now trading at $2.59.
View the best growth stocks for 2024 here.

LM Funding America saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 193,900 shares, an increase of 21.3% from the March 15th total of 159,900 shares. Based on an average daily volume of 141,200 shares, the days-to-cover ratio is currently 1.4 days. Approximately 9.5% of the company's stock are sold short.
View LM Funding America's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our LMFA earnings forecast.

LM Funding America, Inc. (NASDAQ:LMFA) released its quarterly earnings data on Monday, May, 14th. The financial services provider reported $0.03 EPS for the quarter. The financial services provider had revenue of $0.96 million for the quarter. LM Funding America had a negative net margin of 122.79% and a negative trailing twelve-month return on equity of 19.98%.

LM Funding America's stock reverse split on the morning of Tuesday, March 12th 2024. The 1-6 reverse split was announced on Tuesday, March 12th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, March 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other LM Funding America investors own include Citius Pharmaceuticals (CTXR), Rigel Pharmaceuticals (RIGL), OPKO Health (OPK), Ovid Therapeutics (OVID), Veru (VERU), ASAP (WTRH), AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), Avadel Pharmaceuticals (AVDL) and Aytu BioPharma (AYTU).

Shares of LMFA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.